Update and new developments in the management of the exsanguinating patient

Journal of Intensive Care Medicine

Volumn 28, Issue 1, 2013, Pages 46-57

  Riha, Gordon A ^a   Schreiber, Martin A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Damage control; Hemorrhage; Hemostatic resuscitation; Massive transfusion; Massive transfusion protocol

Indexed keywords

BLOOD CLOTTING FACTOR; FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; KAOLIN; PLACEBO; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RINGER LACTATE SOLUTION; SODIUM CHLORIDE; TRANEXAMIC ACID; TROMETAMOL;

ACIDOSIS; ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ALLOIMMUNIZATION; BATTLE INJURY; BLOOD CLOTTING DISORDER; BLOOD EXAMINATION; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; BLUNT TRAUMA; CLINICAL PROTOCOL; CRYSTALLOID; ERYTHROCYTE CONCENTRATE; EXSANGUINATION; FIBRINOLYSIS; FLUID RESUSCITATION; HEMOSTASIS; HUMAN; HYPOTENSION; HYPOTHERMIA; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; IRON OVERLOAD; ISCHEMIA; MEDICAL LITERATURE; MEDICAL RESEARCH; METABOLIC ACIDOSIS; METABOLIC DISORDER; MICROCHIMERISM; MILITARY MEDICINE; MORBIDITY; MORTALITY; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PATIENT CARE; PATIENT MONITORING; PENETRATING TRAUMA; POSTTRANSFUSION PURPURA; PRIORITY JOURNAL; PROTHROMBIN TIME; PURPURA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESUSCITATION; RETROSPECTIVE STUDY; REVIEW; ROTATION THROMBELASTOMETRY; SURVIVAL RATE; THROMBOCYTE TRANSFUSION; THROMBOELASTOGRAPHY; THROMBOSIS; TRANSFUSION ASSOCIATED CIRCULATORY OVERLOAD; TRANSFUSION ASSOCIATED GRAFT VERSUS HOST DISEASE; TRANSFUSION RELATED ACUTE LUNG INJURY; WOUND CLOSURE; WOUND DRESSING;

ANESTHESIA; ANESTHETICS; BLOOD PRESSURE; BLOOD TRANSFUSION; BODY TEMPERATURE; DEXTRANS; HEMORRHAGE; HUMANS; MONITORING, PHYSIOLOGIC; PLASMA SUBSTITUTES; PULSE;

EID: 84875901849     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066611403273     Document Type: Review

References (127)

1. Sauaia A, Moore FA, Moore EE, et al. Epidemiology of trauma deaths: a reassessment. J Trauma Injury Infect Crit Care. 1995; 38(2): 185-193.
2. Peng R, Chang C, Gilmore D, Bongard F. Epidemiology of immediate and early trauma deaths at an urban level I trauma center. Am Surg. 1998;64(10): 950-954.
3. Holcomb JB, Jenkins D, Rhee P, et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma Injury Infect Crit Care. 2007;62(2): 307-310.
4. Hess JR, Holcomb JB. Transfusion practice in military trauma. Transfusion Med. 2008;18(3): 143-150.
5. Teixeira PG, Inaba K, Shulman I, et al. Impact of plasma transfusion in massively transfused trauma patients. J Trauma Injury Infect Crit Care. 2009;66(3): 693-697.
6. Snyder CW,Weinberg JA, McGwin G, Jr., et al. The relationship of blood product ratio to mortality: survival benefit or survival bias? J Trauma Injury Infect Crit Care. 2009;66(2): 358-362.
7. Niles SE, McLaughlin DF, Perkins JG, et al. Increased mortality associated with the early coagulopathy of trauma in combat casualties. J Trauma Injury Infect Crit Care. 2008;64(6): 1459-1463.
8. Cancio LC, Wade CE, West SA, Holcomb JB. Prediction of mortality and of the need for massive transfusion in casualties arriving at combat support hospitals in iraq. J Trauma Injury Infect Crit Care. 2008;64(2 suppl):S51-S55.
9. Sihler KC, Napolitano LM. Massive transfusion: new insights. Chest. 2009;136(6): 1654-1667.
10. Schreiber MA, Perkins J, Kiraly L, Underwood S, Wade C, Holcomb JB. Early predictors of massive transfusion in combat casualties. J Am Coll Surg. 2007;205(4): 541-545.
11. Levy JH, Dutton RP, Hemphill JC, 3rd, et al. Multidisciplinary approach to the challenge of hemostasis. Anesth Analg. 2010; 110(2): 354-364.
12. McLaughlin DF, Niles SE, Salinas J, et al. A predictive model for massive transfusion in combat casualty patients. J Trauma Injury Infect Crit Care. 2008;64(2 suppl):S57-S63.
13. Moore EE. Thomas G. orr memorial lecture. staged laparotomy for the hypothermia, acidosis, and coagulopathy syndrome. Am J Surg. 1996;172(5): 405-410.
14. Kashuk JL, Moore EE, Millikan JS, Moore JB. Major abdominal vascular trauma-a unified approach. J Trauma Injury Infect Crit Care. 1982;22(8): 672-679.
15. Beekley ACFACS. Damage control resuscitation: a sensible approach to the exsanguinating surgical patient. Crit Care Med. 2008;36(7 suppl):S267-S274.
16. Sihler KC, Napolitano LM. Complications of massive transfusion. Chest. 2010;137(1): 209-220.
17. Watts DD, Trask A, Soeken K, Perdue P, Dols S, Kaufmann C. Hypothermic coagulopathy in trauma: effect of varying levels of hypothermia on enzyme speed, platelet function, and fibrinolytic activity. J Trauma Injury Infect Crit Care. 1998;44(5): 846-854.
18. Kermode JC, Zheng Q, Milner EP. Marked temperature dependence of the platelet calcium signal induced by human von willebrand factor. Blood. 1999;94(1): 199-207.
19. Jurkovich GJ, Greiser WB, Luterman A, Curreri PW. Hypothermia in trauma victims: an ominous predictor of survival. J Trauma Injury Infect Crit Care. 1987;27(9): 1019-1024.
20. Djaldetti M, Fishman P, Bessler H, Chaimoff C. pH-induced platelet ultrastructural alterations. A possible mechanism for impaired platelet aggregation. Arch Surg. 1979;114(6): 707-710.
21. Meng ZH, Wolberg AS, Monroe DM 3rd, Hoffman M. The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. J Trauma Injury Infect Crit Care. 2003;55(5): 886-891.
22. Martini WZ, Holcomb JB. Acidosis and coagulopathy: the differential effects on fibrinogen synthesis and breakdown in pigs. Ann Surg. 2007;246(5): 831-835.
23. Cosgriff NM, Ernest E, Sauaia A, Kenny-Moynihan M, Burch JM, Galloway B. Predicting life-threatening coagulopathy in the massively transfused trauma patient: Hypothermia and acidoses revisited. J Trauma Injury Infect Crit Care. 1997; 42(5): 857-862.
24. Hess Jr. Blood and coagulation support in trauma care. Hematology. 2007: 187-191.
25. Hess JR, Holcomb JBMC, Hoyt DB. Damage control resuscitation: the need for specific blood products to treat the coagulopathy of trauma. Transfusion. 2006;46(5): 685-686.
26. Ganter MT, Brohi K, Cohen MJ, et al. Role of the alternative pathway in the early complement activation following major trauma. Shock. 2007;28(1): 29-34.
27. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma Injury Infect Crit Care. 2003;54(6): 1127-1130.
28. Griffee MJ, Deloughery TG, Thorborg PA. Coagulation management in massive bleeding. Curr Opin Anaesthesiol. 2010;23(2): 263-268.
29. Brohi K, Cohen MJ, Ganter MT, Matthay MA, Mackersie RC, Pittet JF. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg. 2007;245(5): 812-818.
30. MacLeod JB, Lynn M, McKenney MG, Cohn SM, Murtha M. Early coagulopathy predicts mortality in trauma. J Trauma Injury Infect Crit Care. 2003;55(1): 39-44.
31. Gonzalez EA, Moore FA, Holcomb JB, et al. Fresh frozen plasma should be given earlier to patients requiring massive transfusion. J Trauma Injury Infect Crit Care. 2007;62(1): 112-119.
32. Rotondo MF, Schwab CW, McGonigal MD, et al. 'Damage control': an approach for improved survival in exsanguinating penetrating abdominal injury. J Trauma Injury Infect Crit Care. 1993;35(3): 375-382.
33. Hirshberg A, Mattox KL. Planned reoperation for severe trauma. Ann Surg. 1995;222(1): 3-8.
34. Alam HB, Chen Z, Jaskille A, et al. Application of a zeolite hemostatic agent achieves 100% survival in a lethal model of complex groin injury in swine. J Trauma Injury Infect Crit Care. 2004; 56(5): 974-983.
35. Pusateri AE, McCarthy SJ, Gregory KW, et al. Effect of a chitosan-based hemostatic dressing on blood loss and survival in a model of severe venous hemorrhage and hepatic injury in swine. J Trauma Injury Infect Crit Care. 2003;54(1): 177-182.
36. Brown MA, Daya MR, Worley JA. Experience with chitosan dressings in a civilian EMS system. J Emerg Med. 2009;37(1): 1-7.
37. Cox ED, Schreiber MA, McManus J, Wade CE, Holcomb JB. New hemostatic agents in the combat setting. Transfusion. 2009;49(suppl 5):248S-55S.
38. Rhee P, Brown C, Martin M, et al. QuikClot use in trauma for hemorrhage control: case series of 103 documented uses. J Trauma Injury Infect Crit Care. 2008;64(4): 1093-1099.
39. Wedmore I, McManus JG, Pusateri AE, Holcomb JB. A special report on the chitosan-based hemostatic dressing: experience in current combat operations. J Trauma-Injury Infect Crit Care. 2006;60(3): 655-658.
40. Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH. A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. Ann Surg. 2010;251(2): 217-228.
41. Vassar MJ, Fischer RP, O'Brien PE, et al. A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran
42. the multicenter group for the study of hypertonic saline in trauma patients. Arch Surg. 1993;128(9): 1003-1011.
43. Solomonov E, Hirsh M, Yahiya A, Krausz MM. The effect of vigorous fluid resuscitation in uncontrolled hemorrhagic shock after massive splenic injury. Crit Care Med. 2000;28(3): 749-754.
44. Stern SA. Low-volume fluid resuscitation for presumed hemorrhagic shock: helpful or harmful? Curr Opin Crit Care. 2001; 7(6): 422-430.
45. Bickell WH, Wall MJ, Jr, Pepe PE, et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med. 1994;331(17): 1105-1109.
46. Dutton RP, Mackenzie CF, Scalea TM. Hypotensive resuscitation during active hemorrhage: impact on in-hospital mortality. J Trauma Injury Infect Crit Care. 2002;52(6): 1141-1146.
47. Yaghoubian A, Lewis RJ, Putnam B, De Virgilio C. Reanalysis of prehospital intravenous fluid administration in patients with penetrating truncal injury and field hypotension. Am Surg. 2007; 73(10): 1027-1030.
48. Skarda DE, Mulier KE, George ME, Bellman GJ. Eight hours of hypotensive versus normotensive resuscitation in a porcine model of controlled hemorrhagic shock. Acad Emerg Med. 2008;15(9): 845-852.
49. Cannon WB. Traumatic Shock. New York: Appleton and Company; 1923.
50. Beecher HK. Resuscitation, and Anesthesia for Wounded Men, the Management of Traumatic Shock. Springfield: Charles C. Thomas; 1949.
51. Sondeen JL, Coppes VG, Holcomb JB. Blood pressure at which rebleeding occurs after resuscitation in swine with aortic injury. J Trauma Injury Infect Crit Care. 2003;54(5 suppl):S110-S117.
52. Todd SR, Malinoski D, Muller PJ, Schreiber MA. Lactated Ringer's is superior to normal saline in the resuscitation of uncontrolled hemorrhagic shock. J Trauma Injury Infect Crit Care. 2007;62(3): 636-639.
53. Kiraly LN, Differding JA, Enomoto TM, et al. Resuscitation with normal saline (NS) vs. lactated ringers (LR) modulates hypercoagulability and leads to increased blood loss in an uncontrolled hemorrhagic shock swine model. J Trauma Injury Infect Crit Care. 2006;61(1): 57-64.
54. Watters JM, Brundage SI, Todd SR, et al. Resuscitation with lactated ringer's does not increase inflammatory response in a swine model of uncontrolled hemorrhagic shock. Shock. 2004; 22: 283-287.
55. Healey MA, Davis RE, Liu FC, Loomis WH, Hoyt DB. Lactated ringer's is superior to normal saline in a model of massive hemorrhage and resuscitation. J Trauma Injury Infect Crit Care. 1998; 45(5): 894-899.
56. Scheingraber S, Rehm M, Sehmisch C, Finsterer U. Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery. Anesthesiology. 1999;90(5): 1265-1270.
57. Waters JH, Gottlieb A, Schoenwald P, Popovich MJ, Sprung J, Nelson DR. Normal saline versus lactated ringer's solution for intraoperative fluid management in patients undergoing abdominal aortic aneurysm repair: an outcome study. Anesth Analg. 2001;93(4): 817-822.
58. Martini WZ, Dubick MA, Pusateri AE, Park MS, Ryan KL, Holcomb JB. Does bicarbonate correct coagulation function impaired by acidosis in swine? J Trauma Injury Infect Crit Care. 2006;61(1): 99-106.
59. Nahas GG, Sutin KM, Fermon C, et al. Guidelines for the treatment of acidaemia with THAM. Drugs. 1998;55(2): 191-224.
60. Weil MH, Tang W. Management of acidosis: the role of buffer agents. Crit Care. 1997;1:51.
61. Lucas CE, Ledgerwood AM. Clinical significance of altered coagulation tests after massive transfusion for trauma. Am Surg. 1981;47(3): 125-130.
62. Cinat ME, Wallace WC, Nastanski F, et al. Improved survival following massive transfusion in patients who have undergone trauma. Arch Surg. 1999;134(9): 964-968.
63. Hirshberg A, Dugas MDO, Banez EI, Scott BG, Wall MJJ, Mattox KL. Minimizing dilutional coagulopathy in exsanguinating hemorrhage: a computer simulation. J Trauma Injury Infect Crit Care. 2003;54(3): 454-463.
64. Ho AMH, Dion PW, Cheng CAY, et al. A mathematical model for fresh frozen plasma transfusion strategies during major trauma resuscitation with ongoing hemorrhage. Can J Surg. 2005; 48(6): 470-478.
65. Repine TB, Perkins JG, Kauvar DS, Blackborne L. The use of fresh whole blood in massive transfusion. J Trauma Injury Infect Crit Care. 2006;60(6 suppl):S59-S69.
66. Spinella PC, Perkins JG, Grathwohl KW, Beekley AC, Holcomb JB. Warm fresh whole blood is independently associated with improved survival for patients with combat-related traumatic injuries. J Trauma Injury Infect Crit Care. 2009;66(4 suppl): S69-S76.
67. Kauvar DS, Holcomb JB, Norris GC, Hess Jr. Fresh whole blood transfusion: A controversial military practice. J Trauma. 2006; 61(1): 181-184.
68. Greer SE, Rhynhart KK, Gupta R, Corwin HL. New developments in massive transfusion in trauma. Curr Opin Anaesthesiol. 2010;23(2): 246-250.
69. Duchesne JC, Hunt JP, Wahl G, et al. Review of current blood transfusions strategies in a mature level I trauma center: were we wrong for the last 60 years? J Trauma Injury Infect Crit Care. 2008;65(2): 272-278.
70. Borgman MA, Spinella PC, Perkins JG, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma Injury Infect Crit Care. 2007;63(4): 805-813.
71. Maegele M, Lefering R, Paffrath T, Tjardes T, Simanski C, Bouillon B. Working Group on Polytrauma of the German Society of Trauma Surgery (DGU). Red-blood-cell to plasma ratios transfused during massive transfusion are associated with mortality in severe multiple injury: A retrospective analysis from the trauma registry of the deutsche gesellschaft fur unfallchirurgie. Vox Sang. 2008;95(2): 112-119.
72. Sperry JL, Ochoa JB, Gunn SR, et al. An FFP:PRBC transfusion ratio >/~1:1.5 is associated with a lower risk of mortality after massive transfusion. J Trauma Injury Infect Crit Care. 2008; 65(5): 986-993.
73. Holcomb JB, Wade CE, Michalek JE, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg. 2008;248(3): 447-458.
74. Zink KA, Sambasivan CN, Holcomb JB, Chisholm G, Schreiber MA. A high ratio of plasma and platelets to packed red blood cells in the first 6 hours of massive transfusion improves outcomes in a large multicenter study. Am J Surg. 2009;197(5): 565-570.
75. Scalea TM, Bochicchio KM, Lumpkins K, et al. Early aggressive use of fresh frozen plasma does not improve outcome in critically injured trauma patients. Ann Surg. 2008;248(4): 578-584.
76. Kashuk JL, Moore EE, Johnson JL, et al. Postinjury life threatening coagulopathy: is 1:1 fresh frozen plasma:packed red blood cells the answer? J Trauma Injury Infect Crit Care. 2008;65(2): 261-270.
77. Gunter OL, Jr, Au BK, Isbell JM, Mowery NT, Young PP, Cotton BA. Optimizing outcomes in damage control resuscitation: identifying blood product ratios associated with improved survival. J Trauma Injury Infect Crit Care. 2008; 65(3): 527-534.
78. Johansson PI, Stensballe J. Hemostatic resuscitation for massive bleeding: the paradigm of plasma and platelets-a review of the current literature. Transfusion. 2010;50(3): 701-710.
79. Hoyt DB, Dutton RP, Hauser CJ, et al. Management of coagulopathy in the patients with multiple injuries: results from an international survey of clinical practice. J Trauma Injury Infect Crit Care. 2008;65(4): 755-764.
80. Cotton BA, Gunter OL, Isbell J, et al. Damage control hematology: the impact of a trauma exsanguination protocol on survival and blood product utilization. J Trauma Injury Infect Crit Care. 2008;64(5): 1177-1182.
81. Dente CJ, Shaz BH, Nicholas JM, et al. Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level I trauma center. J Trauma Injury Infect Crit Care. 2009;66(6): 1616-1624.
82. Johansson PI, Stensballe J. Effect of haemostatic control resuscitation on mortality in massively bleeding patients: a before and after study. Vox Sang. 2009;96(2): 111-118.
83. Nunez TC, Voskresensky IV, Dossett LA, Shinall R, Dutton WD, Cotton BA. Early prediction of massive transfusion in trauma: simple as ABC (assessment of blood consumption)? J Trauma Injury Infect Crit Care. 2009;66(2): 346-352.
84. Sullivan MT, Cotten R, Read EJ, Wallace EL. Blood collection and transfusion in the United States in 2001. Transfusion. 2007; 47(3): 385-394.
85. Scott KL, Lecak J, Acker JP. Biopreservation of red blood cells: past, present, and future. Transfus Med Rev. 2005; 19(2): 127-142.
86. Chin-Yee I, Arya N, d'Almeida MS. The red cell storage lesion and its implication for transfusion. Transfus Sci. 1997;18(3): 447-458.
87. Purdy FR, Tweeddale MG, Merrick PM. Association of mortality with age of blood transfused in septic ICU patients. Can J Anaesth. 1997;44(12): 1256-1261.
88. Zallen G, Offner PJ, Moore EE, et al. Age of transfused blood is an independent risk factor for postinjury multiple organ failure. Am J Surg. 1999;178(6): 570-572.
89. Offner PJ, Moore EE, Biffl WL, Johnson JL, Silliman CC. Increased rate of infection associated with transfusion of old blood after severe injury. Arch Surg. 2002;137(6): 711-716.
90. Tinmouth A, Fergusson D, Yee IC, Hebert PC, I ABLE. Canadian Critical Care Trials G. Clinical consequences of red cell storage in the critically ill. Transfusion. 2006;46(11): 2014-2027.
91. Basran S, Frumento RJ, Cohen A, et al. The association between duration of storage of transfused red blood cells and morbidity and mortality after reoperative cardiac surgery. Anesth Analg. 2006;103(1): 15-20.
92. Koch CG, Li L, Sessler DI, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med. 2008;358(12): 1229-1239.
93. Kiraly LN, Underwood S, Differding JA, Schreiber MA. Transfusion of aged packed red blood cells results in decreased tissue oxygenation in critically injured trauma patients. J Trauma Injury Infect Crit Care. 2009;67(1): 29-32.
94. Hedner U, Erhardtsen E. Potential role for rFVIIa in transfusion medicine. Transfusion. 2002;42(1): 114-124.
95. Armand R, Hess Jr. Treating coagulopathy in trauma patients. Transfus Med Rev. 2003;17(3): 223-231.
96. Boffard KD, Choong PI, Kluger Y, et al. The treatment of bleeding is to stop the bleeding! treatment of trauma-related hemorrhage. Transfusion. 2009;49(suppl 5):240S-7S.
97. Dutton RP, McCunn M, Hyder M, et al. Factor VIIa for correction of traumatic coagulopathy. J Trauma Injury Infect Crit Care. 2004;57(4): 709-718.
98. Martinowitz U,Kenet G, SegalE, et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma Injury Infect Crit Care. 2001;51(3): 431-438.
99. Berkhof FF, Eikenboom JC. Efficacy of recombinant activated factor VII in patients with massive uncontrolled bleeding: a retrospective observational analysis. Transfusion. 2009;49(3): 570-577.
100. Perkins JG, Schreiber MA,Wade CE, Holcomb JB. Early versus late recombinant factor VIIa in combat trauma patients requiring massive transfusion. J Trauma Injury Infect Crit Care. 2007; 62(5): 1095-1099.
101. Boffard KD, Riou B, Warren B, et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma Injury Infect Crit Care. 2005;59(1): 8-15.
102. Kashuk JL, Moore EE, Sawyer M, et al. Postinjury coagulopathy management: goal directed resuscitation via POC thrombelastography. Ann Surg. 2010;251(4): 604-614.
103. Limentani SA, Roth DA, Furie BC, Furie B. Recombinant blood clotting proteins for hemophilia therapy. Semin Thromb Hemost. 1993;19(1): 62-72.
104. Bruce D, Nokes TJ. Prothrombin complex concentrate (beriplex P/N) in severe bleeding: experience in a large tertiary hospital. Crit Care. 2008;12(4):R105.
105. Dickneite G, Pragst I. Prothrombin complex concentrate vs fresh frozen plasma for reversal of dilutional coagulopathy in a porcine trauma model. Br J Anaesth. 2009;102(3): 345-354.
106. Dickneite G, Dorr B, Kaspereit F, Tanaka KA. Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model. J Trauma Injury Infect Crit Care. 2010;68(5): 1151-1157.
107. Fries D, Haas T, Klingler A, et al. Efficacy of fibrinogen and prothrombin complex concentrate used to reverse dilutional coagulopathy- a porcine model. Br J Anaesth. 2006;97(4): 460-467.
108. Solomon C, Pichlmaier U, Schoechl H, et al. Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery. Br J Anaesth. 2010;104(5): 555-562.
109. Schochl H, Nienaber U, Hofer G, et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care. 2010;14(2):R55.
110. Okamoto S, Hijikata-Okunomiya A, Wanaka K, Okada Y, Okamoto U. Enzyme-controlling medicines: introduction. Semin Thromb Hemost. 1997;23(6): 493-501.
111. Henry DA, Carless PA, Moxey AJ, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2007(4):001886.
112. CRASH-2 trial c, Shakur H, Roberts R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH- 2): a randomised, placebo-controlled trial. Lancet. 2010; 376(9734): 23-32.
113. Hoffman M, Monroe DM. Coagulation 2006: a modern view of hemostasis. Hematol Oncol Clin North Am. 2007;21(1): 1-11.
114. Segal JB, Dzik WH. Transfusion medicine/hemostasis clinical trials network. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion. 2005; 45(9): 1413-1425.
115. Triulzi DJ. Transfusion-related acute lung injury: current concepts for the clinician. Anesth Analg. 2009;108(3): 770-776.
116. Goldman M, Webert KE, Arnold DM, et al. Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev. 2005;19(1): 2-31.
117. Khan H, Belsher J, Yilmaz M, et al. Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest. 2007; 131(5): 1308-1314.
118. Silliman CC, Boshkov LK, Mehdizadehkashi Z, et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood. 2003;101(2): 454-462.
119. Gajic O, Rana R, Mendez JL, et al. Acute lung injury after blood transfusion in mechanically ventilated patients. Transfusion. 2004;44(10): 1468-1474.
120. Holness L, Knippen MA, Simmons L, Lachenbruch PA. Fatalities caused by TRALI. Transfus Med Rev. 2004;18(3): 184-188.
121. Gajic O, Dzik WH, Toy P. Fresh frozen plasma and platelet transfusion for nonbleeding patients in the intensive care unit: Benefit or harm? Crit Care Med. 2006;34(5 suppl): S170-S173.
122. Toy P, Popovsky MA, Abraham E, et al. Transfusion-related acute lung injury: definition and review. Crit Care Med. 2005; 33(4): 721-726.
123. Bux J, Sachs UJ. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol. 2007;136(6): 788-799.
124. Sachs UJ. Pathophysiology of TRALI: current concepts. Intensive Care Med. 2007;33(suppl 1):S3-S11.
125. Chapman CE, Stainsby D, Jones H, et al. Ten years of hemovigilance reports of transfusion-related acute lung injury in the united kingdom and the impact of preferential use of male donor plasma. Transfusion. 2009;49(3): 440-452.
126. Hendrickson JE, Hillyer CD. Noninfectious serious hazards of transfusion. Anesth Analg. 2009;108(3): 759-769.
127. Dodd RY. Current risk for transfusion transmitted infections. Curr Opin Hematol. 2007;14(6): 671-676.